The report sums up the development of the global and Chinese pharmaceutical markets in 2004. Through accurate data and full elaboration, it presents the status, features and competition pattern of China's pharmaceutical market. Meanwhile, it makes a comprehensive evaluation of the operational strategies and competitiveness of key enterprises in the industry.

The report especially points out the following: In 2004, China's pharmaceutical industry continued to maintain a momentum of steady growth, achieving a stable rise in both output and sales revenues. Exports maintained a stable growth and there was a continuous improvement in the industry's international competitiveness. Market competition changed from pure pursuit of market shares to comprehensive competition based on multiple factors. Competition among brands intensified. Among the industry segments, the chemical preparation industry   was in steady growth, while the raw chemical material industry grew slowly. Traditional Chinese medicine was in a stage of combination with modern technologies, while the biopharmaceutical industry was in an early period of growth and was moving towards more R&D activities. 

Based on an in-depth analysis of major factors affecting the development of China's pharmaceutical industry from 2005 to 2009, the report presents qualitative and quantitative forecast of the development trend of the industry. It also evaluates investment values in the industry. Finally, it provides pertinent development strategies and recommendations for the government, enterprise and investors respectively.

2.Overview of Development of China's Pharmaceutical Industry in 2004
2.1 Growth Environment
2.1.1 Policy Environment
2.1.2 Investment Environment
2.1.3 Economic Environment
2.2 Development Status
2.3 Basic Characteristics
2.4 Industry Segments
2.4.1 Chemical Bulk Drug Manufacturing Industry
2.4.2 Traditional Chinese Medicine Manufacturing Industry
2.4.3 Biological Pharmaceutical Manufacturing Industry

3.Competition Situation and Behavior in China's Pharmaceutical Industry in 2004
3.1 Competition Situation
3.1.1 Chemical Bulk Drug Manufacturing Industry
3.1.2 Traditional Chinese Medicine Manufacturing Industry
3.1.3 Biological Pharmaceutical Manufacturing Industry
3.2 Competition Behavior
3.2.1 Chemical Bulk Drug Manufacturing Industry
3.2.2 Traditional Chinese Medicine Manufacturing Industry
3.2.3 Biological Pharmaceutical Manufacturing Industry
3.3 Competition Performance
3.3.1 Chemical Bulk Drug Manufacturing Industry
3.3.2 Traditional Chinese Medicine Manufacturing Industry
3.3.3 Biological Pharmaceutical Manufacturing Industry

4.Evaluation of Competitiveness of Key Enterprises in China's Pharmaceutical Industry in 2004

5.Analysis of Driving Forces for Growth of China's Pharmaceutical Industry, 2005-2009
5.1 Policy Factor
5.2 Technological Factor
5.3 Talent Factor
5.4 Capital Factor
5.5 Economic Factor

6.Analysis of Development Trend of China's Pharmaceutical Industry, 2005-2009
6.1 Trend of Industry Development
6.2 Trend of Competition Development
6.3 Trend of Structural Development

7.Forecast for Development of China's Pharmaceutical Industry, 2005-2009
7.1 Forecast for Industry Size
7.2 Forecast for Market Pattern

8.Analysis of Investment Opportunities in China's Pharmaceutical Industry, 2005-2009
8.1 Evaluation of Investment Values In Industry
8.1.1 Chemical Bulk Drug Manufacturing Industry
8.1.2 Traditional Chinese Medicine Manufacturing Industry
8.1.3 Biological Pharmaceutical Manufacturing Industry
8.2 Analysis of Investment Opportunities
8.2.1 Chemical Bulk Drug Manufacturing Industry
8.2.2 Traditional Chinese Medicine Manufacturing Industry
8.2.3 Biological Pharmaceutical Manufacturing Industry

9.Recommendations